Assessing immune response upon systemic RNA vaccination on [18F]-FDG PET/CT for COVID-19 vaccine and then for immuno-oncology?

Seban, Romain-David; Champion, Laurence; Yeh, Randy; Schwartz, Lawrence H; Dercle, Laurent

Seban, Romain-David; Champion, Laurence; Yeh, Randy; Schwartz, Lawrence H; Dercle, Laurent.

Seban RD; Department of Nuclear Medicine, Institut Curie, 92210, Saint-Cloud, France. romain.seban@gmail.com.
Champion L; Laboratoire D'Imagerie Translationnelle en Oncologie, Inserm, Institut Curie, 91401, Orsay, France. romain.seban@gmail.com.
Yeh R; Department of Nuclear Medicine, Institut Curie, 92210, Saint-Cloud, France.
Schwartz LH; Laboratoire D'Imagerie Translationnelle en Oncologie, Inserm, Institut Curie, 91401, Orsay, France.
Dercle L; Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Eur J Nucl Med Mol Imaging ; 48(11): 3351-3352, 2021 10.

Article in English | MEDLINE | ID: covidwho-1281265

Subject(s)

COVID-19; Neoplasms; COVID-19 Vaccines; Fluorodeoxyglucose F18; Humans; Immunity; Neoplasms/diagnostic imaging; Positron Emission Tomography Computed Tomography; RNA; Radiopharmaceuticals; SARS-CoV-2; Vaccination

Keywords

COVID-19; Immuno-oncology; RNA vaccination; [18F]-FDG PET/CT

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Neoplasms Topics: Vaccines Limits: Humans Language: English Journal: Eur J Nucl Med Mol Imaging Journal subject: Nuclear Medicine Year: 2021 Document Type: Article Affiliation country: S00259-021-05468-z

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google